WebJul 20, 2024 · Biogen BIIB will report second-quarter 2024 results on Jul 22, before market open. In the last reported quarter, the company delivered an earnings surprise of 5.53%. WebFeb 3, 2024 · Earlier, Biogen expected Aduhelm sales to increase in 2024 after remaining modest in 2024. Adjusted earnings are expected in a range of $14.25-$16.00, which also falls significantly short of the ...
Inventiva S.A. (NASDAQ:IVA) Q4 2024 Earnings Call Transcript
WebOct 20, 2024 · As of September 30, 2024, there was $2.8 billion remaining under the share repurchase program authorized in October of 2024. Our weighted average diluted share count was approximately 149 million shares for the quarter. Non-GAAP diluted earnings per share in the third quarter was $4.77. WebJul 20, 2024 · Biogen Reports Second Quarter 2024 Results. Second quarter revenue $2,589 million; GAAP diluted EPS $7.24; Non-GAAP diluted EPS $5.25. FDA granted Priority Review for lecanemab in early Alzheimer's disease under the accelerated approval pathway with a decision expected by January 6, 2024; Phase 3 data expected in the Fall … greer attorney
Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT
WebJul 22, 2024 · Latest Biogen News: View BIIB news and discuss market sentiment with the investor community on Public.com ... Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2024 Results - Earnings Call Transcript. Seeking Alpha • 07/22/20. Biogen Beats Second-Quarter Expectations. ... 6 Warren Buffett Stocks That Could Soar as 2024 Approaches. … WebMay 3, 2024 · Q2 2024 Biogen Earnings Presentation. Jul 20, 2024. Q1 2024 Biogen Earnings Presentation. May 03, 2024. ... Biogen Analyst Q&A Call. Jan 13, 2024. … WebJul 22, 2024 · The company raised its total revenue guidance for 2024 while maintaining its earnings expectations. Total revenues are expected in the range of $10.65-$10.85 billion in 2024 compared with $10.45 ... fob irish pub